|
1.
|
|
Isolation of a new human pseudogene for proliferating cell nuclear antigen. 1992/01
|
|
2.
|
|
Quantification of the c-myc gene in gastric carcinomas by the triplex polymerase chain reaction and high performance liquid chromatography. 1992/01
|
|
3.
|
|
Nucleotide sequence of a human genomic DNA fragment containing the PCNA
pseudogene and its localization on chromosome 4. 1994/09
|
|
4.
|
|
Cloning, sequencing, and chromosomal localization of two tandemly arranged human pseudogenes for the proliferating cell nuclear antigen (PCNA). 1996/12
|
|
5.
|
|
Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. 2000/03
|
|
6.
|
|
T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice. 2000/03
|
|
7.
|
|
Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. 2000/03/01
|
|
8.
|
|
Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. 2000/08
|
|
9.
|
|
Selection and Characterization of MUC1-specific CD8+ T cells from MUC1 transgenic mice immunized with dendritic-carcinoma fusion cells. 2000/11/01
|
|
10.
|
|
Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells potenitiated by interleukin 12. 2002/04
|
|
11.
|
|
Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic / tumor fusion cells. 2003/02
|
|
12.
|
|
Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. 2003/06
|
|
13.
|
|
Development of antigen-specific CD8+ CTL in MHC class I-deficient mice through CD4 to CD8 conversion. 2004/06
|
|
14.
|
|
The kinetics of in vivo priming of CD4 and CD8 T cells by dendritic / tumor fusion cells in MUC1-transgenic mice. 2004/06
|
|
15.
|
|
Vaccination with allogeneic dendritic cells fused to carcinoma cells induces antitumor immunity in MUC1 transgenic mice. 2004/06
|
|
16.
|
|
Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation. 2004/12
|
|
17.
|
|
Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts. 2004/12
|
|
18.
|
|
Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells. 2005/02
|
|
19.
|
|
Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use. 2005/11
|
|
20.
|
|
Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. 2005/11
|
|
21.
|
|
Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells. 2005/11
|
|
22.
|
|
Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells. 2007/01/01
|
|
23.
|
|
Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells. 2007/03
|
|
24.
|
|
Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation. 2007/08
|
|
25.
|
|
Dendritic/tumor fusion cell-based vaccination against cancer. 2007/09/30
|
|
26.
|
|
Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated
dendritic cells and heat-stressed tumor cells. 2007/10/01
|
|
27.
|
|
Cell fusion: from hybridoma to dendritic cell-based vaccine. 2008/09
|
|
28.
|
|
In vitro generation of cytotoxic and regulatory T cells by fusions of human
dendritic cells and hepatocellular carcinoma cells. 2008/09/15
|
|
29.
|
|
Significance of thymidine phosphorylase expression in stromal cells around
invasive front of rectal cancer. 2008/11
|
|
30.
|
|
Cancer immunotherapy by fusions of dendritic cells and tumor cells. 2009/01/01
|
|
31.
|
|
A novel magnetic crystal-lipid nanostructure for magnetically-guided in vivo gene delivery. 2009/04/01
|
|
32.
|
|
Antigenic stimulation with cytochrome P450 2J expressed in mouse hepatocellular carcinoma cells regulates host anti-tumour immunity. 2009/05/01
|
|
33.
|
|
Antigenic stimulation with cytochrome P450 2J expressed in mouse hepatocellular carcinoma cells regulates host antitumor immunity. 2009/05/01
|
|
34.
|
|
Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. 2009/11/01
|
|
35.
|
|
Cancer vaccine by fusions of dendritic and cancer cells. 2009/12/09
|
|
36.
|
|
Combined treatment with dendritic cells and 5-fluorouracil elicits augmented NK-cell-mediated antitumor activity via the tumor necrosis factor-alpha pathway. 2010/01
|
|
37.
|
|
A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use. 2010/01/01
|
|
38.
|
|
Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells. 2010/02/01
|
|
39.
|
|
n-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. 2010/04
|
|
40.
|
|
Dendritic/pancreatic carcinoma fusions for clinical use: comparative functional analysis of healthy- versus patient-derived fusions. 2010/04/01
|
|
41.
|
|
Regulation of tumor immunity by tumor/dendritic cell fusions. 2010/10/01
|
|
42.
|
|
Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines. 2011/03/01
|
|
43.
|
|
Corticotropin releasing factor secretion by dendritic cells in response to stimulation by commensal bacteria. 2011/03/31
|
|
44.
|
|
Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells. 2011/03/31
|
|
45.
|
|
Gemcitabine enhances Wilms’tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T cell-mediated antitumor immune response. 2011/05/01
|
|
46.
|
|
Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in the patients with advanced pancreatic carcinoma. 2011/05/10
|
|
47.
|
|
Current Immunotherapeutic approaches in Pancreatic Cancer. 2011/06/26
|
|
48.
|
|
Inorganic-organic magnetic nanocomposites for use in preventive medicine: A rapid and eliable elimination system for cesium 2011/12/07
|
|
49.
|
|
Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. 2012/01/01
|
|
50.
|
|
Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers 2012/01/25
|
|
51.
|
|
Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in the patients with advanced pancreatic carcinoma. 2012/03/01
|
|
52.
|
|
Immunotherapy for Pancreatic Cancer 2012/03/03
|
|
53.
|
|
Suppressive effects on regulatory T cell induction by cyclophosphamide and gemcitabine in vitro 2012/12/01
|
|
54.
|
|
Challenge for treatment of unresectable pancreatic cancer. 2013/01/01
|
|
55.
|
|
A nested culture method improves the detection of Fusobacterium from stool in ulcerative colitis. 2013/02/01
|
|
56.
|
|
Characterization of structure and direct antigen presentation by dendritic/tumor fused cells as cancer vaccines. 2013/02/01
|
|
57.
|
|
Fusions between dendritic cells and whole tumor cells as cancer vaccines. 2013/02/01
|
|
58.
|
|
Combined TLR2/4-activated dendritic/tumor cell fusions induce augmented cytotoxic T lymphocytes. 2013/03/01
|
|
59.
|
|
Prognostic impact of expression of Bcl-2 and Bax genes in circulating immune cells derived from patients with head and neck carcinoma. 2013/03/01
|
|
60.
|
|
Augmentation of antitumor immunity by fusions of ethanol-treated tumor cells and dendritic cells stimulated via dual TLRs through TGF-β1 blockade and IL-12p70 production. 2013/05/01
|
|
61.
|
|
Identification of HLA class I-binding peptides derived from unique cancer-associated proteins by mass spectrometric analysis. 2013/05/01
|
|
62.
|
|
The fatty acid profile of the erythrocyte membrane in the initial-onset inflammatory bowel disease patients. 2013/05/01
|
|
63.
|
|
Immuno-chemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T-cell 1 response by 5-FU and X-ray irradiation. 2013/07/01
|
|
64.
|
|
The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions. 2013/07/01
|
|
65.
|
|
Unusual images of mass-forming intrahepatic cholangiocarcinoma. 2013/07/01
|
|
66.
|
|
Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation. 2013/07/15
|
|
67.
|
|
Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation. 2013/07/15
|
|
68.
|
|
Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer. 2013/07/20
|
|
69.
|
|
Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation. 2013/08/01
|
|
70.
|
|
Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions. 2013/09/01
|
|
71.
|
|
Clinical significance of serum procalcitonin in patients with ulcerative colitis. 2013/12/01
|
|
72.
|
|
Immunotherapy for colorectal cancer. 2013/12/01
|
|
73.
|
|
Seasonal variations in the onset of ulcerative colitis in Japan. World J Gastroenterol 2013 19(47):9063-9068. 2013/12/21
|
|
74.
|
|
Photodynamic diagnosis of colitis-associated dysplasia in a mouse model after oral administration of 5-aminolevulinic acid. . 2013 27(6): 2013/12/27
|
|
75.
|
|
Characterization of non-alcoholic steatohepatitis-derived hepatocellular carcinoma as a human stratification model in mice. 2014/01/01
|
|
76.
|
|
Combined onset of bilateral endophthalmitis and spondylodiscitis as manifestations of streptococcus dysgalactiae infection in an elderly woman. 2014/01/01
|
|
77.
|
|
Immunological assessment of cryotherapy in breast cancer patients. 2014/01/01
|
|
78.
|
|
Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy. 2014/01/01
|
|
79.
|
|
Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing hemodialysis. 2014/01/01
|
|
80.
|
|
Production of corticotropin-releasing factor and urocortin from human monocyte-derived dendritic cells is stimulated by commensal bacteria. 2014/01/01
|
|
81.
|
|
Repetitive acute cholangitis and pancreatitis due to Lemmel syndrome: A case report. 2014/01/01
|
|
82.
|
|
Tumor Regression by CD4 T Cells Primed With Dendritic/Tumor Fusion Cell Vaccines. 2014/01/01
|
|
83.
|
|
Clinical role of Helicobacter pylori infection and eradication in the development of gastric cancer. 2014/02/01
|
|
84.
|
|
Edwardsiella tarda superinfection in relapse of ulcerative colitis. 2014/02/01
|
|
85.
|
|
Chemoimmunotherapy targeting Wilms’ tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer. 2014/03/01
|
|
86.
|
|
Wilms’ tumor gene 1 (WT1)-peptide based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer. 2014/03/01
|
|
87.
|
|
Hybrid microparticles as a magnetically-guidable decontaminant for cesium-eluted ash slurry. 2014/04/01
|
|
88.
|
|
Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells. 2014/05/01
|
|
89.
|
|
Factors associated with incomplete colonoscopy at a Japanese academic hospital. 2014/06/01
|
|
90.
|
|
Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells. 2014/07/01
|
|
91.
|
|
Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms’ tumor gene 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. 2014/08/01
|
|
92.
|
|
Characterization of non-alcoholic steatohepatitis-derived hepatocellular carcinoma as a human stratification model in mice. 2014/09/01
|
|
93.
|
|
Combinatorial contextualization of peptidic epitopes for enhanced cellular immunity. 2014/09/01
|
|
94.
|
|
Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma. 2014/09/01
|
|
95.
|
|
Initial experience of percutaneous cryoablation to treat small cancer of the breast. 2014/12/01
|
|
96.
|
|
Prognostic markers for patient outcome following vaccination with multiple MHC class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancer. 2015/01/01
|
|
97.
|
|
Dendritic/tumor fusion cells in cancer immunotherapy. 2015/03
|
|
98.
|
|
Induction of antigen-specific cytotoxic Tlymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells. 2015/04/06
|
|
99.
|
|
Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine. 2015/07
|
|
100.
|
|
Direct comparison of esomeprazole with other proton pump inhibitors on intragastric pH >4. 2015/07/01
|
|
101.
|
|
A prospective study evaluating metabolic capacity of thiopurine and associated adverse reactions in Japanese patients with inflammatory bowel disease (IBD). 2015/09
|
|
102.
|
|
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy. 2015/10
|
|
103.
|
|
Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model. 2015/12/01
|
|
Display 5 items
|
|
Display all(103)
|
